Literature DB >> 20735426

Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels.

Y Majeed1, A K Agarwal, J Naylor, V A L Seymour, S Jiang, K Muraki, C W G Fishwick, D J Beech.   

Abstract

BACKGROUND AND
PURPOSE: The transient receptor potential melastatin-3 (TRPM3) channel forms calcium-permeable, non-selective, cationic channels that are stimulated by pregnenolone sulphate (PregS). Here, we aimed to define chemical requirements of this acute steroid action and potentially reveal novel stimulators with physiological relevance. EXPERIMENTAL APPROACH: We used TRPM3 channels over-expressed in HEK 293 cells, with intracellular calcium measurement and whole-cell patch-clamp recording techniques. KEY
RESULTS: The stimulation of TRPM3 channels was confined to PregS and closely related steroids and not mimicked by other major classes of steroids, including progesterone. Relatively potent stimulation of TRPM3-dependent calcium entry was observed. A sulphate group positioned at ring A was important for strong stimulation but more striking was the requirement for a cis (beta) configuration of the side group, revealing previously unrecognized stereo-selectivity and supporting existence of a specific binding site. A cis-oriented side group on ring A was not the only feature necessary for high activity because loss of the double bond in ring B reduced potency and loss of the acetyl group at ring D reduced efficacy and potency. Weak steroid stimulators of TRPM3 channels inhibited effects of PregS, suggesting partial agonism. In silico screening of chemical libraries for non-steroid modulators of TRPM3 channels revealed the importance of the steroid backbone for stimulatory effects. CONCLUSIONS AND IMPLICATIONS: Our data defined some of the chemical requirements for acute stimulation of TRPM3 channels by steroids, supporting the existence of a specific and unique steroid binding site. Epipregnanolone sulphate was identified as a novel TRPM3 channel stimulator.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735426      PMCID: PMC2989593          DOI: 10.1111/j.1476-5381.2010.00892.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Alternative splicing switches the divalent cation selectivity of TRPM3 channels.

Authors:  Johannes Oberwinkler; Annette Lis; Klaus M Giehl; Veit Flockerzi; Stephan E Philipp
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

2.  Serum profiles of free and conjugated neuroactive pregnanolone isomers in nonpregnant women of fertile age.

Authors:  Helena Havlíková; Martin Hill; Lyudmila Kancheva; Jana Vrbíková; Vladimír Pouzar; Ivan Cerny; Radmila Kancheva; Luboslav Stárka
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

3.  Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites.

Authors:  M Park-Chung; A Malayev; R H Purdy; T T Gibbs; D H Farb
Journal:  Brain Res       Date:  1999-05-29       Impact factor: 3.252

4.  Modulation of GABAA receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model.

Authors:  P Poisbeau; P Feltz; R Schlichter
Journal:  J Physiol       Date:  1997-04-15       Impact factor: 5.182

Review 5.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members.

Authors:  M J Tsai; B W O'Malley
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

6.  Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected].

Authors:  Christian Grimm; Robert Kraft; Günter Schultz; Christian Harteneck
Journal:  Mol Pharmacol       Date:  2004-11-18       Impact factor: 4.436

7.  Residues in the first transmembrane domain of the Caenorhabditis elegans GABA(A) receptor confer sensitivity to the neurosteroid pregnenolone sulfate.

Authors:  Bryan Wardell; Purba S Marik; David Piper; Tina Rutar; Erik M Jorgensen; Bruce A Bamber
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 8.  Pregnenolone sulfate in the brain: a controversial neurosteroid.

Authors:  Michael Schumacher; Philippe Liere; Yvette Akwa; Krzysztof Rajkowski; William Griffiths; Karl Bodin; Jan Sjövall; Etienne-Emile Baulieu
Journal:  Neurochem Int       Date:  2007-10-09       Impact factor: 3.921

9.  Circulating levels of pregnanolone isomers during the third trimester of human pregnancy.

Authors:  Martin Hill; David Cibula; Helena Havlíková; Lyudmila Kancheva; Tomás Fait; Radmila Kancheva; Antonín Parízek; Luboslav Stárka
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-16       Impact factor: 4.292

Review 10.  Neurosteroids as modulators of neurogenesis and neuronal survival.

Authors:  Ioannis Charalampopoulos; Eumorphia Remboutsika; Andrew N Margioris; Achille Gravanis
Journal:  Trends Endocrinol Metab       Date:  2008-09-02       Impact factor: 12.015

View more
  25 in total

1.  Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.

Authors:  Paula A Zamudio-Bulcock; Julie Everett; Christian Harteneck; C Fernando Valenzuela
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

Review 2.  TRPM3_miR-204: a complex locus for eye development and disease.

Authors:  Alan Shiels
Journal:  Hum Genomics       Date:  2020-02-18       Impact factor: 4.639

3.  Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel.

Authors:  Wenzhen Ma; Xingjuan Chen; Rok Cerne; Samreen K Syed; James V Ficorilli; Over Cabrera; Alexander G Obukhov; Alexander M Efanov
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

4.  Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels.

Authors:  Yasser Majeed; Yahya Bahnasi; Victoria A L Seymour; Lesley A Wilson; Carol J Milligan; Anil K Agarwal; Piruthivi Sukumar; Jacqueline Naylor; David J Beech
Journal:  Mol Pharmacol       Date:  2011-03-15       Impact factor: 4.436

Review 5.  Steroids, steroid associated substances and gestational diabetes mellitus.

Authors:  M Hill; A Pařízek; P Šimják; M Koucký; K Anderlová; H Krejčí; D Vejražková; L Ondřejíková; A Černý; R Kancheva
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

6.  CREB, AP-1, ternary complex factors and MAP kinases connect transient receptor potential melastatin-3 (TRPM3) channel stimulation with increased c-Fos expression.

Authors:  Sandra Rubil; Oliver G Rössler; Gerald Thiel
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

7.  Activation and inhibition of transient receptor potential TRPM3-induced gene transcription.

Authors:  Andrea Lesch; Sandra Rubil; Gerald Thiel
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

8.  Functional expression and pharmacological modulation of TRPM3 in human sensory neurons.

Authors:  Laura Vangeel; Melissa Benoit; Yannick Miron; Paul E Miller; Katrien De Clercq; Patrick Chaltin; Catherine Verfaillie; Joris Vriens; Thomas Voets
Journal:  Br J Pharmacol       Date:  2020-03-05       Impact factor: 8.739

9.  Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids.

Authors:  Y Majeed; M S Amer; A K Agarwal; L McKeown; K E Porter; D J O'Regan; J Naylor; C W G Fishwick; K Muraki; D J Beech
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

10.  Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone.

Authors:  Yasser Majeed; Sarka Tumova; Ben L Green; Victoria A L Seymour; Daniel M Woods; Anil K Agarwal; Jacqueline Naylor; Shannon Jiang; Helen M Picton; Karen E Porter; David J O'Regan; Katsuhiko Muraki; Colin W G Fishwick; David J Beech
Journal:  Cell Calcium       Date:  2011-10-14       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.